Apoptosis, DAP-Kinase1 Expression and the Influences of Cytokine Milieu and Mesenchymal Stromal Cells on Ex Vivo Expansion of Umbilical Cord Blood-Derived Hematopoietic Stem Cells

Overview

Journal Indian J Hematol Blood Transfus

Specialty Hematology

Date 2016 Feb 9

PMID 26855509

Citations 1

Authors

Naser Amirizadeh

Arezoo Oodi

Roya Mehrasa

Mahin Nikougoftar

Affiliations

Soon will be listed here.

Abstract

Expansion of umbilical cord blood-derived CD34(+) cells can potentially provide them in numbers sufficient for clinical applications in adult humans. In this study apoptosis rate of expanded cells, mRNA expression and promoter methylation status of DAPK1 were evaluated during cord blood hematopoietic stem cell (CB-HSC) ex vivo expansion using cytokines and a co-culture system with mesenchymal stromal cells (MSCs). Ex vivo cultures of CB-HSCs were performed in three culture conditions for 14 days: cytokines with MSCs feeder layer, cytokines without MSCs feeder layer and co-culture with MSCs feeder layer without cytokine. Total number of cells, CD34(+) cells and colony forming unit assay were performed during expansion. Flow cytometric analysis by propidium iodide was performed to detection of apoptosis rate in expanded cells. Methylation status of the DAPK1 gene promoter was analyzed using methylation specific PCR, and DAPK1 mRNA expression was evaluated by real time-PCR. Maximum CB-CD34(+) cells expansion was observed in day 10 of expansion. The highest apoptosis rate was observed in cytokine culture without feeder layer that showed significant difference with co-culture condition. The data showed that ex vivo expansion of CD34(+) cells in all three culture conditions after 10 days resulted in, significant increased expression of DAPK1, also a significant difference between co-culture without cytokine and two other cytokine culture was observed (p < 0.01). DAPK1gene promoter of expanded CD34(+) cells at days 5, 10 and 14 of culture remained in unmethylated form similar to fresh CD34(+) cells. Expression of DAPK1 in hematopoietic cells was increased during 10 days expansion of CD34(+) cells. Also no methylation of DAPK1 promoter was observed; otherwise it would be capable of initiating some leukemic cell progression or disruption in hematopoietic regeneration.

Citing Articles

The Effect of Mesenchymal Stem Cell-Derived Extracellular Vesicles on Hematopoietic Stem Cells Fate.

Timari H, Shamsasenjan K, Movassaghpour A, Akbarzadehlaleh P, Pashoutan Sarvar D, Aqmasheh S Adv Pharm Bull. 2018; 7(4):531-546.

PMID: 29399543 PMC: 5788208. DOI: 10.15171/apb.2017.065.

References

Wagner W, Saffrich R, Ho A . The Stromal Activity of Mesenchymal Stromal Cells. Transfus Med Hemother. 2011; 35(3):185-193. PMC: 3083286. DOI: 10.1159/000128956. View

Wei Z, Chen N, Guo H, Wang X, Xu F, Ren Q . Bone marrow mesenchymal stem cells from leukemia patients inhibit growth and apoptosis in serum-deprived K562 cells. J Exp Clin Cancer Res. 2009; 28:141. PMC: 2779804. DOI: 10.1186/1756-9966-28-141. View

Sanchez-Cespedes M, Esteller M, Wu L, Yoo G, Koch W, Jen J . Gene promoter hypermethylation in tumors and serum of head and neck cancer patients. Cancer Res. 2000; 60(4):892-5. View

Qian J, Yao D, Lin J, Wang Y, Han L, Xu W . Methylation of DAPK1 promoter: frequent but not an adverse prognostic factor in myelodysplastic syndrome. Int J Lab Hematol. 2009; 32(1 Pt 2):74-81. DOI: 10.1111/j.1751-553X.2008.01131.x. View

Jones P, Baylin S . The epigenomics of cancer. Cell. 2007; 128(4):683-92. PMC: 3894624. DOI: 10.1016/j.cell.2007.01.029. View

Wagner W, Saffrich R, Wirkner U, Eckstein V, Blake J, Ansorge A . Hematopoietic progenitor cells and cellular microenvironment: behavioral and molecular changes upon interaction. Stem Cells. 2005; 23(8):1180-91. DOI: 10.1634/stemcells.2004-0361. View

Conrad P, Emerson S . Ex vivo expansion of hematopoietic cells from umbilical cord blood for clinical transplantation. J Leukoc Biol. 1998; 64(2):147-55. DOI: 10.1002/jlb.64.2.147. View

Issa J . Epigenetic changes in the myelodysplastic syndrome. Hematol Oncol Clin North Am. 2010; 24(2):317-30. PMC: 2848959. DOI: 10.1016/j.hoc.2010.02.007. View

Song Y, Bahnson A, Hall N, Yu H, Shen H, Koebler D . Stem cell traits in long-term co-culture revealed by time-lapse imaging. Leukemia. 2009; 24(1):153-61. PMC: 2806505. DOI: 10.1038/leu.2009.191. View

10.

Delaney C, Ratajczak M, Laughlin M . Strategies to enhance umbilical cord blood stem cell engraftment in adult patients. Expert Rev Hematol. 2010; 3(3):273-83. PMC: 2935587. DOI: 10.1586/ehm.10.24. View

11.

Hopfer O, Komor M, Koehler I, Schulze M, Hoelzer D, Thiel E . DNA methylation profiling of myelodysplastic syndrome hematopoietic progenitor cells during in vitro lineage-specific differentiation. Exp Hematol. 2007; 35(5):712-23. DOI: 10.1016/j.exphem.2007.01.054. View

12.

Gade P, Singh A, Roy S, Reddy S, Kalvakolanu D . Down-regulation of the transcriptional mediator subunit Med1 contributes to the loss of expression of metastasis-associated dapk1 in human cancers and cancer cells. Int J Cancer. 2009; 125(7):1566-74. PMC: 4010141. DOI: 10.1002/ijc.24493. View

13.

Oguro H, Iwama A . Life and death in hematopoietic stem cells. Curr Opin Immunol. 2007; 19(5):503-9. DOI: 10.1016/j.coi.2007.05.001. View

14.

Zou J, Zou P, Wang J, Li L, Wang Y, Zhou D . Inhibition of p38 MAPK activity promotes ex vivo expansion of human cord blood hematopoietic stem cells. Ann Hematol. 2012; 91(6):813-23. PMC: 3390192. DOI: 10.1007/s00277-011-1397-7. View

15.

Wulf-Goldenberg A, Eckert K, Fichtner I . Cytokine-pretreatment of CD34(+) cord blood stem cells in vitro reduces long-term cell engraftment in NOD/SCID mice. Eur J Cell Biol. 2007; 87(2):69-80. DOI: 10.1016/j.ejcb.2007.08.001. View

16.

Greco M, DAlo F, Scardocci A, Criscuolo M, Fabiani E, Guidi F . Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms. Blood Cells Mol Dis. 2010; 45(3):181-5. DOI: 10.1016/j.bcmd.2010.05.008. View

17.

Cohen O, Kimchi A . DAP-kinase: from functional gene cloning to establishment of its role in apoptosis and cancer. Cell Death Differ. 2001; 8(1):6-15. DOI: 10.1038/sj.cdd.4400794. View

18.

Feinberg A, Ohlsson R, Henikoff S . The epigenetic progenitor origin of human cancer. Nat Rev Genet. 2005; 7(1):21-33. DOI: 10.1038/nrg1748. View

19.

Traycoff C, Orazi A, Ladd A, Rice S, McMahel J, Srour E . Proliferation-induced decline of primitive hematopoietic progenitor cell activity is coupled with an increase in apoptosis of ex vivo expanded CD34+ cells. Exp Hematol. 1998; 26(1):53-62. View

20.

Tung S, Parmar S, Robinson S, de Lima M, Shpall E . Ex vivo expansion of umbilical cord blood for transplantation. Best Pract Res Clin Haematol. 2010; 23(2):245-57. DOI: 10.1016/j.beha.2010.06.004. View